Abstract
The incidence of thyroid cancer is increasing rapidly. A large percentage of new cases identified fall into a low-risk category. As the incidence has increased, clinical experience has confirmed that the majority of patients will have excellent outcomes and that those at risk of doing badly can be reliably identified. Treatment for thyroid cancer is predominantly surgical. The decision about how aggressively this disease should be managed has remained controversial due to the excellent outcomes irrespective of the nature of surgical procedure chosen. This article reviews the developments in our understanding of the biology of thyroid cancer and the evidence that supports the approach to management.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference41 articles.
1. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985–2010.;B Amphlett;Thyroid.,2013
2. Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006.;B Aschebrook-Kilfoy;Thyroid.,2011
3. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005.;A Chen;Cancer.,2009
4. Increasing incidence of thyroid cancer in the United States, 1973–2002.;L Davies;JAMA.,2006
5. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005.;L Enewold;Cancer Epidemiol Biomarkers Prev.,2009
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献